BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 31778315)

  • 1. Quantification of plan robustness against different uncertainty sources for classical and anatomical robust optimized treatment plans in head and neck cancer proton therapy.
    Cubillos-Mesías M; Troost EGC; Lohaus F; Agolli L; Rehm M; Richter C; Stützer K
    Br J Radiol; 2020 Mar; 93(1107):20190573. PubMed ID: 31778315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Including anatomical variations in robust optimization for head and neck proton therapy can reduce the need of adaptation.
    Cubillos-Mesías M; Troost EGC; Lohaus F; Agolli L; Rehm M; Richter C; Stützer K
    Radiother Oncol; 2019 Feb; 131():127-134. PubMed ID: 30773179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anatomic changes in head and neck intensity-modulated proton therapy: Comparison between robust optimization and online adaptation.
    Lalonde A; Bobić M; Winey B; Verburg J; Sharp GC; Paganetti H
    Radiother Oncol; 2021 Jun; 159():39-47. PubMed ID: 33741469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of robust optimization in intensity-modulated proton therapy planning for head and neck cancers.
    Liu W; Frank SJ; Li X; Li Y; Park PC; Dong L; Ronald Zhu X; Mohan R
    Med Phys; 2013 May; 40(5):051711. PubMed ID: 23635259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Robust optimization for intensity-modulated proton therapy with soft spot sensitivity regularization.
    Gu W; Ruan D; O'Connor D; Zou W; Dong L; Tsai MY; Jia X; Sheng K
    Med Phys; 2019 Mar; 46(3):1408-1425. PubMed ID: 30570164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of linear and nonlinear programming approaches for "worst case dose" and "minmax" robust optimization of intensity-modulated proton therapy dose distributions.
    Zaghian M; Cao W; Liu W; Kardar L; Randeniya S; Mohan R; Lim G
    J Appl Clin Med Phys; 2017 Mar; 18(2):15-25. PubMed ID: 28300378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose uncertainties in IMPT for oropharyngeal cancer in the presence of anatomical, range, and setup errors.
    Kraan AC; van de Water S; Teguh DN; Al-Mamgani A; Madden T; Kooy HM; Heijmen BJ; Hoogeman MS
    Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):888-96. PubMed ID: 24351409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Superiority in Robustness of Multifield Optimization Over Single-Field Optimization for Pencil-Beam Proton Therapy for Oropharynx Carcinoma: An Enhanced Robustness Analysis.
    Stützer K; Lin A; Kirk M; Lin L
    Int J Radiat Oncol Biol Phys; 2017 Nov; 99(3):738-749. PubMed ID: 29280468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of robust treatment planning on single- and multi-field optimized plans for proton beam therapy of unilateral head and neck target volumes.
    Cubillos-Mesías M; Baumann M; Troost EGC; Lohaus F; Löck S; Richter C; Stützer K
    Radiat Oncol; 2017 Nov; 12(1):190. PubMed ID: 29183377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PTV-based VMAT vs. robust IMPT for head-and-neck cancer: A probabilistic uncertainty analysis of clinical plan evaluation with the Dutch model-based selection.
    Rojo-Santiago J; Korevaar E; Perkó Z; Both S; Habraken SJM; Hoogeman MS
    Radiother Oncol; 2023 Sep; 186():109729. PubMed ID: 37301261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Limited Impact of Setup and Range Uncertainties, Breathing Motion, and Interplay Effects in Robustly Optimized Intensity Modulated Proton Therapy for Stage III Non-small Cell Lung Cancer.
    Inoue T; Widder J; van Dijk LV; Takegawa H; Koizumi M; Takashina M; Usui K; Kurokawa C; Sugimoto S; Saito AI; Sasai K; Van't Veld AA; Langendijk JA; Korevaar EW
    Int J Radiat Oncol Biol Phys; 2016 Nov; 96(3):661-9. PubMed ID: 27681763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pre-treatment analysis of non-rigid variations can assist robust intensity-modulated proton therapy plan selection for head and neck patients.
    Zhang Y; Alshaikhi J; Amos RA; Tan W; Anaya VM; Pang Y; Royle G; Bär E
    Med Phys; 2022 Dec; 49(12):7683-7693. PubMed ID: 36083223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statistical evaluation of worst-case robust optimization intensity-modulated proton therapy plans using an exhaustive sampling approach.
    Yang Z; Li H; Li Y; Li Y; Chang Y; Li Q; Yang K; Wu G; Sahoo N; Poenisch F; Gillin M; Zhu XR; Zhang X
    Radiat Oncol; 2019 Jul; 14(1):129. PubMed ID: 31324257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Analysis of Plan Robustness for Esophageal Tumors: Comparing Volumetric Modulated Arc Therapy Plans and Spot Scanning Proton Planning.
    Warren S; Partridge M; Bolsi A; Lomax AJ; Hurt C; Crosby T; Hawkins MA
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):199-207. PubMed ID: 27084641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PTV-based IMPT optimization incorporating planning risk volumes vs robust optimization.
    Liu W; Frank SJ; Li X; Li Y; Zhu RX; Mohan R
    Med Phys; 2013 Feb; 40(2):021709. PubMed ID: 23387732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inter-fraction robustness of intensity-modulated proton therapy in the post-operative treatment of oropharyngeal and oral cavity squamous cell carcinomas.
    Hague C; Aznar M; Dong L; Fotouhi-Ghiam A; Lee LW; Li T; Lin A; Lowe M; Lukens JN; McPartlin A; O'Reilly S; Slevin N; Swisher-Mcclure S; Thomson D; Van Herk M; West C; Zou W; Teo BK
    Br J Radiol; 2020 Mar; 93(1107):20190638. PubMed ID: 31845816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploratory Study of 4D versus 3D Robust Optimization in Intensity Modulated Proton Therapy for Lung Cancer.
    Liu W; Schild SE; Chang JY; Liao Z; Chang YH; Wen Z; Shen J; Stoker JB; Ding X; Hu Y; Sahoo N; Herman MG; Vargas C; Keole S; Wong W; Bues M
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):523-533. PubMed ID: 26725727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of robustness against setup uncertainties using probabilistic scenarios in lung cancer: a comparison of proton with photon therapy.
    Teoh S; George B; Fiorini F; Vallis KA; Van den Heuvel F
    Br J Radiol; 2020 Mar; 93(1107):20190584. PubMed ID: 31977241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improve the dosimetric outcome in bilateral head and neck cancer (HNC) treatment using spot-scanning proton arc (SPArc) therapy: a feasibility study.
    Liu G; Li X; Qin A; Zheng W; Yan D; Zhang S; Stevens C; Kabolizadeh P; Ding X
    Radiat Oncol; 2020 Jan; 15(1):21. PubMed ID: 32000817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Robust optimization to reduce the impact of biological effect variation from physical uncertainties in intensity-modulated proton therapy.
    Bai X; Lim G; Grosshans D; Mohan R; Cao W
    Phys Med Biol; 2019 Jan; 64(2):025004. PubMed ID: 30523932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.